Powell Michael is a director of Galera Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Galera Therapeutics, Inc.
16 Jun 23
4
Galera Therapeutics, Inc.
16 Jun 22
4
Checkmate Pharmaceuticals, Inc.
31 May 22
4
Checkmate Pharmaceuticals, Inc.
10 Aug 21
4
Checkmate Pharmaceuticals, Inc.
21 Jun 21
4
Galera Therapeutics, Inc.
17 Jun 21
4
Vera Therapeutics, Inc.
18 May 21
3
Vera Therapeutics, Inc.
13 May 21
4
Management X, L.L.C. Sofinnova
9 Feb 21
3
Management X, L.L.C. Sofinnova
4 Feb 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 23 | GRTX Galera Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.27 | 64,000 | 209.28 k | 64,000 |